17-β-hydroxysteroid dehydrogenase type 3 deficiency: Identifying a rare cause of 46, XY female phenotype in adulthood

Phelan, 2015, Screening for mutations in 17β-hydroxysteroid dehydrogenase and androgen receptor in women presenting with partially virilised 46, XY disorders of sex development, Eur J Endocrinol, 172, 745, 10.1530/EJE-14-0994 Lee, 2016, Global disorders of sex development update since 2006: perceptions, approach and care, Horm Res Paediatr, 85, 158, 10.1159/000442975 Berglund, 2016, Incidence, prevalence, diagnostic delay, and clinical presentation of female 46, XY disorders of sex development, J Clin Endocrinol Metab, 12, 4532, 10.1210/jc.2016-2248 Boehmer, 1999, 17β-Hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population Genetics, and worldwide distribution of ancient and de Novo mutations, J Clin Endocrinol Metab, 84, 4713 Castro, 2012, Clinical and molecular spectrum of patients with 17β-hydroxysteroid dehydrogenase type 3 (17-β-HSD3) deficiency, Arq Bras Endocrinol Metab, 56, 533, 10.1590/S0004-27302012000800012 Faienza, 2012, InTech Gottlieb, 1999, Androgen insensitivity syndrome, 1993 Lee, 2008, Disorders of sexual differentiation in the adolescent, Ann N. Y Acad Sci, 67, 10.1196/annals.1429.028 Grimbly, 2016, 46,XY disorder of sex development due to 17-beta hydroxysteroid dehydrogenase type 3 deficiency: a plea for timely genetic testing, Int J Pediatr Endocrinol, 2016, 12, 10.1186/s13633-016-0030-x